FTC:WATCH No. 587 (2002-8)

April 22, 2002

Washington, D.C.


Biovail must dismiss patent suit

Rx industry antitrust red flags

Anthony on dietary supplement claims

Public comments on disgorgement

Leary on "Clinical Integration"...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch